Rationalizing the Activities of Diverse Cholecystokinin 2 Receptor Antagonists Using Molecular Field Points-Reference-Cited by-同舟云学术

Rationalizing the Activities of Diverse Cholecystokinin 2 Receptor Antagonists Using Molecular Field Points

Published:2008-01-18 Issue:3 Volume:51 Page:565-573
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Low Caroline M. R.¹,Vinter J. G.¹

Affiliation:

1. James Black Foundation, 68 Half Moon Lane, London, SE24 9JE, United Kingdom, and Cresset BioMolecular Discovery Ltd., BioPark Hertfordshire, Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AX, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm070880t

Reference40 articles.

1. Gastrin

2. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor

3. Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

4. Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic Skeletons

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of molecular field points using SE(3)-transformer model;Machine Learning: Science and Technology;2023-08-01

2. Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models;iScience;2021-09

3. Preliminary modelling as the first stage of targeted organic synthesis;Russian Chemical Reviews;2021-08-01

4. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors;Breast Cancer Research and Treatment;2018-07-24

5. Lessons and Successes in the Use of Molecular Fields;Comprehensive Medicinal Chemistry III;2017